N-Glycosylation on Asn50 of SND1 Is Required for Glioma U87 Cell Proliferation and Metastasis

Figure 1

Expression level of SND1 gene in different cancers and pathological stages. The expression status of the human SND1 gene in different cancers tissues (a), (b) GBM, or specific GBM subtypes (c) was analyzed through GEPIA 2 (http://gepia2.cancer-pku.cn/#analysis). (d) Immunohistochemical staining of SND1 in clinical glioma tissue samples and normal brain tissues were obtained from the Human Protein Atlas (http://www.proteinatlas.org). Normal tissue, access numbers: NOS (M-00100), patient ID: 1582; glioma, malignant: low grade (M-938031), Patient ID: 3120; glioma, malignant: high grade (M-938033), patient ID: 46. (e) The effect of SND1 on the overall survival and disease-free survival of glioblastoma patients was acquired from GEPIA 2.

(a)

(b)

(c)

(d)

(e)